The International Assoc. Of Who’s Who Recognizes Dr. Louis Fernand Fabre as Professional of the Year
Dr. Louis F. Fabre, of San Antonio, Texas is recognized by the International Assoc. of Who’s Who for exemplary achievements in the field of Psychiatry.
San Antonio, TX, March 15, 2018 --(PR.com)-- With more than four decades’ experience in his field, Dr. Louis Fernand Fabre is a seasoned expert and a developer behind some of the world’s most commonly prescribed psychiatric medications.
His medical career began in 1966, when he set out to study for his MD from the Baylor College of Medicine in Houston, Texas. He graduated in 1971 and chose to stay on at Baylor College for the duration of both his internship and residency. He qualified and was certified by the American Board of Psychiatry and Neurology, as well as pursuing a Doctor of Philosophy degree, before embarking on a career in psychiatry.
Throughout his career, Dr. Fabre has gained a wealth of experience in every facet of his field. For the first several decades of his career, he was instrumental in the clinical development of a range of psychiatric medications, with twenty-six of his twenty-nine developments being approved around the world, and more than half achieving United States approval. His work involved clinical trials - with Dr. Fabre being present for many of the first human trials conducted - as well as writing protocols and participating in the arrangement of clinical development plans.
His developments included some of the most widely-prescribed psychiatric drugs, including Prozac, Paxil, Zoloft, Desyrel, Effexor, Xanax, Halcion, Seroquel, Wellbutrin, Celexa and Ascendin.
In his treatment of patients, Dr. Fabre works across the age spectrum, including adolescents and children, and his vast experience in the development and trialing of psychiatric medications has seen him renowned as one of the top experts in medication management of a range of conditions, including anxiety, psychotic disorders and mood disorders. He has also authored more than two hundred medical papers on the subject and given over a thousand lectures.
Dr. Fabre’s latest appointment is at the Alamo Mental Health Group in San Antonio, Texas, a private mental health facility that offers a full-service psychiatric clinic. Here, he sees upwards of thirty patients every day. He is adamant that maintaining expert status depends heavily on regular interaction with patients. His latest drug development is an antidepressant medication that increases sexual function, in efforts to counteract a common side effect of such medication. Outside of work, Dr. Fabre enjoys flying.
His medical career began in 1966, when he set out to study for his MD from the Baylor College of Medicine in Houston, Texas. He graduated in 1971 and chose to stay on at Baylor College for the duration of both his internship and residency. He qualified and was certified by the American Board of Psychiatry and Neurology, as well as pursuing a Doctor of Philosophy degree, before embarking on a career in psychiatry.
Throughout his career, Dr. Fabre has gained a wealth of experience in every facet of his field. For the first several decades of his career, he was instrumental in the clinical development of a range of psychiatric medications, with twenty-six of his twenty-nine developments being approved around the world, and more than half achieving United States approval. His work involved clinical trials - with Dr. Fabre being present for many of the first human trials conducted - as well as writing protocols and participating in the arrangement of clinical development plans.
His developments included some of the most widely-prescribed psychiatric drugs, including Prozac, Paxil, Zoloft, Desyrel, Effexor, Xanax, Halcion, Seroquel, Wellbutrin, Celexa and Ascendin.
In his treatment of patients, Dr. Fabre works across the age spectrum, including adolescents and children, and his vast experience in the development and trialing of psychiatric medications has seen him renowned as one of the top experts in medication management of a range of conditions, including anxiety, psychotic disorders and mood disorders. He has also authored more than two hundred medical papers on the subject and given over a thousand lectures.
Dr. Fabre’s latest appointment is at the Alamo Mental Health Group in San Antonio, Texas, a private mental health facility that offers a full-service psychiatric clinic. Here, he sees upwards of thirty patients every day. He is adamant that maintaining expert status depends heavily on regular interaction with patients. His latest drug development is an antidepressant medication that increases sexual function, in efforts to counteract a common side effect of such medication. Outside of work, Dr. Fabre enjoys flying.
Contact
International Association of Who's Who
Jacob Ryder
212-658-1452
theintlwhoswho.com
Jacob Ryder
212-658-1452
theintlwhoswho.com
Contact
Categories